Posted in | News | Materials Research

Framework for Chemical Risk Management under REACH Released

iSmithers Rapra Publishing has announced the release of Framework for Chemical Risk Management under REACH. Written by Steffen Erler who is a recognized authority in regulatory and research consultancy concerning REACH.

Since 2008, the EU system for the Registration, Evaluation and Authorization of Chemicals (REACH) has begun impacting companies across the world. Today, efficient and effective implementation of REACH continues to depend on the interaction of Member State regulators during EU decision making. This is the result of past political debates surrounding the legislation being narrowly focused on mechanisms for conducting hazard assessments. To facilitate EU decision making, Framework for Chemical Risk Management under REACH presents a possible framework for risk management under REACH.

As a first step, the regulatory approaches of four prominent countries in EU decision making are analyzed and compared: France, Germany, Sweden and the UK. On the basis of 36 interviews conducted with regulators and stakeholder representatives, the study examines how these Member States influence EU chemical regulation, and vice versa. From these findings, the research concludes that a framework for EU decision making must incorporate hazard, technical and risk-benefit approaches to risk management. As a final step, the potential operability of the proposed framework is tested using risk assessment data for 33 chemicals subject to regulatory review. Whether elements of the framework are adopted by the European Chemicals Agency, the European Commission and Member States remains to be seen.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.